Evidence map›Paper›PMID 39839462›Full record

ArticleJAAD case reports2025

Alopecia and hair repigmentation associated with anti-programmed death-ligand 1 (PD-L1) immunotherapy.

Jennifer Strong, Vincent I Poon, Patrick Hallaert, Deneise Francis, Danielle M Pastor, Leslie Castelo-Soccio, Julius Strauss, Isaac Brownell

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in JAAD case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jennifer StrongDermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, Maryland.
Vincent I PoonCenter for Immuno-Oncology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Patrick HallaertDermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, Maryland.
Deneise FrancisOffice of Research Nursing, National Cancer Institute, Center for Cancer Research, National Institutes of Health, Bethesda, Maryland.
Danielle M PastorCenter for Immuno-Oncology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Leslie Castelo-SoccioDermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, Maryland.
Julius StraussCenter for Immuno-Oncology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Isaac BrownellDermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, Maryland.

Funding

Investigation of skin cancer and skin diseaseZIAAR041224 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI BROWNELL, ISAAC · 2022 to 2025
$1.0M
Intramural NIH HHS ZIA AR041224
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

alopecia areatacheckpoint inhibitorshair repigmentationimmune-related adverse eventimmunotherapy

Identifiers

PMID39839462
PMCPMC11750434

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.